<i>Rroid2</i> regulates effector-to-memory CD8 <sup>+</sup> T cell differentiation during infection in vivo

J Julia Erber (Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center) C Carmen Stecher (Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center) V Valerie Plajer (Department of Immunobiology, Yale School of Medicine) N Nina Braun (Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center) W William Mallard (Department of Stem Cell and Regenerative Biology, Harvard University) L Loyal A. Goff (Department of Neuroscience, Johns Hopkins University) I Iros Barozzi (Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center) T Thomas Mohr (Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center) J John L. Rinn (BioFrontiers Institute, University of Colorado Boulder) R Richard A. Flavell (Department of Immunobiology, Yale School of Medicine) D Dietmar Herndler-Brandstetter (Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center)

Abstract

CD8 + T cell differentiation has been associated with changes in the expression of long noncoding RNAs (lncRNAs). Yet, which and how lncRNAs regulate CD8 + T cell responses following infection in vivo remains incompletely understood. We performed deep RNA-seq to map the lncRNA expression landscape of CD8 + T cell subsets during infection and generated lncRNA knockout mouse models to evaluate the in vivo relevance of six lncRNAs. We identified Rroid2 to regulate effector CD8 + T cell function and effector-to-memory differentiation. Rroid2 -deficient mice displayed increased CD44 dim Foxp3 + regulatory T cells while the development of other immune cells, such as natural killer cells, was not affected. In CD8 + T cells, Rroid2 deficiency resulted in a fine-tuned downregulation of transcription factors Id2 and T-bet and impaired KLRG1 + and KLRG1 − effector CD8 + T cell proliferation and cytotoxicity as well as effector-to-memory CD8 + T cell differentiation. The human orthologue of Rroid2 , LINC01814 , is also upstream of the transcriptional regulator ID2 and is highly expressed in human memory CD8 + T cells. Taken together, Rroid2 represents a key regulatory layer that controls CD8 + T cell differentiation.

Article Details

Volume / Issue Vol. 122, Issue 48
Published December 02, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (11)

J

Julia Erber

Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center

C

Carmen Stecher

Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center

V

Valerie Plajer

Department of Immunobiology, Yale School of Medicine

N

Nina Braun

Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center

W

William Mallard

Department of Stem Cell and Regenerative Biology, Harvard University

L

Loyal A. Goff

Department of Neuroscience, Johns Hopkins University

I

Iros Barozzi

Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center

T

Thomas Mohr

Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center

J

John L. Rinn

BioFrontiers Institute, University of Colorado Boulder

R

Richard A. Flavell

Department of Immunobiology, Yale School of Medicine

D

Dietmar Herndler-Brandstetter

Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center